Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders.

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 244 participants.

Also called NCT05774288

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 244 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05774288
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05774288. Randomized; no masking; primary purpose treatment. Start 2023-06-08 (actual); primary completion 2025-04-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders.
Condition
Patent Foramen Ovale
Condition
Cryptogenic Stroke
Intervention (Device)
Cera™ patent foramen ovale occluders
Intervention (Device)
Another patent foramen ovale occluders
Lead sponsor
Lifetech Scientific (Shenzhen) Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct05774288
Content hash
fa6980279cf28d6bf5c8cc65c3e239e3dea5914a9253fa6c60d2a57c875c6a4b